Virus-like particles: flexible platforms for vaccine development
Top Cited Papers
- 1 June 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 6 (3) , 381-390
- https://doi.org/10.1586/14760584.6.3.381
Abstract
Virus-like particles (VLPs) consist of viral structural proteins that, when overexpressed, spontaneously self-assemble into particles that are antigenically indistinguishable from infectious virus or subviral particles. VLPs can be considered as dense, repetitive arrays of one or more protein subunits with properties that are highly advantageous for use as stand-alone vaccines or as vaccine platforms. This review discusses the development of VLP-based platform technologies for vaccines against pathogens, as well as nontraditional targets such as self-antigens involved in chronic diseases.Keywords
This publication has 101 references indexed in Scilit:
- Incorporation of Glycosylphosphatidylinositol-Anchored Granulocyte- MacrophageColony-Stimulating Factor or CD40 Ligand Enhances Immunogenicity of Chimeric Simian Immunodeficiency Virus-Like ParticlesJournal of Virology, 2007
- A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicityJournal Of Hypertension, 2007
- Combinatorial Approach to Hepadnavirus-Like Particle Vaccine DesignJournal of Virology, 2005
- Safety and Enhanced Immunogenicity of a Hepatitis B Core ParticlePlasmodium falciparumMalaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I TrialInfection and Immunity, 2005
- Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles ExpressingPlasmodium falciparumCircumsporozoite EpitopesInfection and Immunity, 2004
- Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit BJournal of Virology, 2003
- Natural Supramolecular Building BlocksChemistry & Biology, 2002
- NEUTRALIZING ANTIVIRAL B CELL RESPONSESAnnual Review of Immunology, 1997
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- The Hepatitis Nucleocapsid as a Vaccine Carrier MoietyAnnals of the New York Academy of Sciences, 1995